Clinical trial
Post Marketing Surveillance for Finerenone Chronic Heart Failure in Korea
NCT07379840 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance for Finerenone Chronic Heart Failure in Korea
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 23, 2025
- Completion date
- September 30, 2027
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure